The Macudine Mouthwash from Dongkook - Korean pharmacy staple with cavity-care focus

By Julian Reed, ad hoc news Bestsellers & Flagships Desk. Reviewed July 06, 2026, 6:15 PM ET. Details in the imprint.

Macudine Mouthwash sits in a clear amber bottle on the counter of a Seoul pharmacy, the sharp antiseptic scent hitting your nose even before the cap twists off. On a quick swish, the iodine tint and medicinal taste leave a clinical clean feeling that regular mint rinses rarely match.

What Macudine Mouthwash actually is

Macudine Mouthwash is an over-the-counter oral antiseptic produced by Dongkook, built around povidone-iodine as its active ingredient for disinfecting the mouth and throat. The product is typically positioned in Korean pharmacies as a treatment and preventive rinse for oral infections, sore throat, and post-dental care.

According to Dongkook’s own Korean-language product information, Macudine Mouthwash is formulated to reduce bacterial load in the oral cavity, helping support dental hygiene, alleviate halitosis caused by microbial growth, and assist recovery after minor oral procedures. It is sold primarily in Korea as a pharmacy product rather than a global consumer brand.

Ingredients, strength, and how it works

Povidone-iodine, the same broad-spectrum antiseptic often used in hospitals for skin disinfection, is the core of Macudine Mouthwash, typically in an approximate 0.5% to 1% available iodine concentration adapted for oral use. Around it, Dongkook blends excipients to stabilize the solution, manage viscosity, and moderate taste and staining.

The iodine complex works by disrupting microbial cell walls and proteins, killing a wide range of bacteria, some viruses, and fungi on contact. In an oral rinse, this translates into reduced plaque-forming bacteria and a lower risk of localized infections, though long-term daily use is generally not recommended without guidance from a dentist or physician.

Use cases beyond a minty rinse

In practice, Korean dentists and pharmacists often recommend povidone-iodine mouthwashes like Macudine after tooth extraction, periodontal treatment, or when patients present with recurrent sore throats linked to upper-respiratory infections. The stronger medicinal profile positions it as a short-term therapeutic tool rather than a cosmetic daily rinse.

Clinical literature on povidone-iodine oral rinses indicates they can significantly reduce oral microbial counts and may help lower viral load in the upper respiratory tract, including coronaviruses, under controlled conditions. However, Macudine Mouthwash is marketed as a general antiseptic, not as a specialty antiviral product or as a substitute for standard medical treatment.

How it compares with US-market mouthwashes

For US readers, Macudine Mouthwash is not broadly marketed in American drugstores, where major brands focus on fluoridated and essential-oil-based rinses rather than povidone-iodine. Products like Listerine and Crest mouthwashes prioritize plaque reduction, cavity protection, and cosmetic breath-freshening, backed by years of US advertising.

By contrast, Macudine’s target consumer is more likely a Korean patient walking out of a clinic with a dentist’s slip recommending a short course of antiseptic gargling, accepting the brown iodine color and medicinal taste as part of a treatment routine instead of a daily lifestyle habit. That gives the product a more clinical, pharmacy-counter identity than its US counterparts.

Regulatory position and safety profile

Dongkook sells Macudine Mouthwash under Korea’s pharmaceutical and quasi-drug regulations, which govern labeling, indications, and allowed concentrations of active antiseptics in oral-care products. As a povidone-iodine rinse, it carries standard warnings for users with iodine sensitivity or thyroid disorders, and for children.

Medical guidance generally suggests limiting prolonged, high-frequency use of iodine-based oral rinses, particularly in patients with thyroid disease or pregnant and breastfeeding individuals, and recommends consulting a physician before use. Like other powerful antiseptics, overuse may disrupt normal oral flora, so careful adherence to labeled directions and professional advice is emphasized.

Packaging, format, and sensory feel

Macudine Mouthwash usually ships in compact plastic bottles in the 120 ml to 250 ml range, sized for short treatment cycles rather than the large 1-liter bottles common in US retail mouthwashes. The amber hue helps protect iodine from light, consistent with other povidone-iodine solutions in hospital supply chains.

On first use, the liquid pours slightly viscous compared with plain water, and the color is unmistakably brownish-orange rather than the blue or green associated with mint rinses. The taste is medicinal, dominated by iodine, with almost no attempt to mask the flavor aggressively with sweeteners.

Distribution in Korea and export potential

Dongkook, headquartered in Seoul, has built Macudine Mouthwash as a staple in domestic pharmacy distribution, integrated in its broader portfolio of hospital injectables, pain medications, and OTC products. The brand benefits from Dongkook’s long-standing relationships with Korean dental clinics and ENT practices, reinforcing its role as a recommended therapeutic rinse.

Export-wise, Dongkook’s focus has historically skewed toward active pharmaceutical ingredients and specialized hospital products in markets such as Southeast Asia rather than mass-market oral-care brands in North America. That helps explain the limited visibility of Macudine Mouthwash on US shelves, even though povidone-iodine mouthwashes exist in various generic forms globally.

The business relevance for Dongkook

Within Dongkook’s portfolio, oral-care and ENT-focused antiseptics, including Macudine Mouthwash, contribute to a diversified OTC segment that complements more capital-intensive hospital drugs. For CEO Kim Young-hwan, maintaining strong presence in Korean pharmacies through such everyday products stabilizes revenue while the company pursues higher-value pharmaceuticals.

While Dongkook does not break out Macudine Mouthwash as a standalone line item in public financial filings, OTC products collectively form a meaningful recurring income stream in the company’s domestic business. Dongkook stock (KRX: 086450, ISIN KR7086450004) trades on the Korea Exchange, giving Korean investors direct exposure to these pharmacy-driven revenues.

This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.

en | KR7086450004 | DONGKOOK | boerse | 69708805 | bgmi